One study found that the positive rates of MUC1 and MUC2 in urothelial carcinoma were 89.7% and 44.3%, respectively, and MUC1 expression was significantly correlated with tumor grade, while MUC2 was the opposite. The gene discussed is MUC2; the disease is urothelial carcinoma.